Enalare Therapeutics Inc.
NJ Enalare Therapeutics Inc.
- UEI
- MDJFW877BCV6
- CAGE
- 8G2D2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- South Jersey Technology Park, 107 Gilbreth Pkwy, Mullica Hill, NJ 08062, USA
- Website
- enalare.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Enalare therapeutics: an agnostic respiratory stimulant for use as a medical countermeasure to treat respiratory… | Office of the Assistant Secretary for Preparedness and Response | $12,209,278 | |
| Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit)… | National Institute on Drug Abuse | $8,136,760 | |
| Enalare therapeautics, INC.: repurposing drugs in response to chemical threats (redirect) ENA-001 | Office of the Assistant Secretary for Preparedness and Response | $749,000 |
About Enalare Therapeutics Inc.
Enalare Therapeutics Inc. is a for-profit pharmaceutical company focused on developing respiratory stimulant therapeutics. The company has received several federal contract and grant awards from agencies like the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) to support its drug development efforts.
Through federal contracts, Enalare has worked on developing an "agnostic respiratory stimulant" as a medical countermeasure to treat respiratory depression. One major $50.8 million contract from HHS's Biomedical Advanced Research and Development Authority (BARDA) aims to advance Enalare's candidate respiratory stimulant towards FDA approval or licensure for this purpose. Another $749,000 firm-fixed price BARDA contract supports Enalare's research into host-directed therapeutics to mitigate long-term effects of lung injury under BARDA's Easy Broad Agency Announcement initiative.
On the federal grant side, Enalare received a $639,406 project grant from NIH's National Institute on Drug Abuse to fund Phase 1 and 2 clinical trials of its lead compound ENA-001. This grant is supporting research into ENA-001 as a potential treatment for respiratory depression caused by opioid or polysubstance overdose. The trials will characterize the pharmacokinetics, safety, and efficacy of intravenous and intramuscular dosing of ENA-001 in stimulating ventilation without reversing opioid analgesia or precipitating withdrawal. The results will guide further development of ENA-001 for this therapeutic indication.
Quick answers
What is Enalare Therapeutics Inc.'s UEI?
Enalare Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is MDJFW877BCV6.
What is Enalare Therapeutics Inc.'s CAGE code?
Enalare Therapeutics Inc.'s CAGE code is 8G2D2.
What is Enalare Therapeutics Inc.'s primary NAICS code?
Enalare Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Enalare Therapeutics Inc. located?
Enalare Therapeutics Inc.'s physical address in SAM.gov is South Jersey Technology Park, 107 Gilbreth Pkwy, Mullica Hill, NJ 08062, USA.
Is Enalare Therapeutics Inc. registered in SAM.gov?
Yes. Enalare Therapeutics Inc.'s SAM.gov registration is active through September 9, 2027.
What is Enalare Therapeutics Inc.'s most recent federal award?
Enalare Therapeutics Inc.'s most recent federal contract award is Enalare therapeutics: an agnostic respiratory stimulant for use as a medical countermeasure to treat respiratory… (75A50122C00072), from Office of the Assistant Secretary for Preparedness and Response, on September 22, 2022.
On GovTribe
See Enalare Therapeutics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors